<DOC>
	<DOC>NCT01061333</DOC>
	<brief_summary>This study will assess the Early Airway Response (EAR) associated change in forced expiratory volume in one second (FEV1) and plasma 9α-11ß-PGF2 ('9P') after single dose pretreatment of nedocromil, montelukast, and mometasone.</brief_summary>
	<brief_title>Early Airway Response to Allergen in Asthmatics (MK-0000-176)</brief_title>
	<detailed_description />
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Nedocromil</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>History of mild to moderate Asthma In good general health (except for asthma) Stable and free of respiratory infection Nonsmoker Females highly unlikely to conceive (surgically sterilized, postmenopausal, or agrees to use 2 acceptable methods of birth control) Nursing mother Recent or ongoing upper or lower respiratory tract infection Unable to refrain from or anticipates the use of any prescription and nonprescription drugs Consumes excessive amounts of alcohol or caffeine History of stroke, chronic seizures, or major neurological disorder History of cancer Received a vaccination within the past 3 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>